YHB Investment Advisors Inc. Sells 2,501 Shares of Colgate-Palmolive (NYSE:CL)

YHB Investment Advisors Inc. reduced its holdings in Colgate-Palmolive (NYSE:CL) by 15.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,589 shares of the company’s stock after selling 2,501 shares during the quarter. YHB Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,235,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CL. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive in the 3rd quarter worth $64,000. Finally, True Wealth Design LLC boosted its stake in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CL shares. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. UBS Group cut their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Trading Up 3.8 %

CL stock opened at $91.19 on Tuesday. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The stock has a market cap of $74.50 billion, a price-to-earnings ratio of 26.13, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The company has a fifty day moving average price of $91.81 and a two-hundred day moving average price of $97.45. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.19%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.